Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients
about
Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assayPhysiological effects and therapeutic potential of proinsulin C-peptideAnti-inflammatory properties of C-Peptide.Insulin therapy for pre-hyperglycemic beta-cell endoplasmic reticulum crowding.Type 1 diabetes: A predictable disease.The clinical potential of C-peptide replacement in type 1 diabetes.C-Peptide and vascular complications in type 2 diabetic subjects.Interaction between peroxisome proliferator- activated receptor gamma polymorphism and overweight on diabetic retinopathy in a Chinese case-control study.Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a reviewThe clinical utility of C-peptide measurement in the care of patients with diabetesThe clinical measures associated with C-peptide decline in patients with type 1 diabetes over 15 years.Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.Vitamin D Deficiency and Cardio-Metabolic Risk in a North Indian Community with Highly Prevalent Type 2 DiabetesCardiac autonomic neuropathy in patients with diabetes mellitus.C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study.C-peptide and long-term complications of diabetes.Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants.Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?Painful and painless diabetic neuropathy: one disease or two?C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.The therapeutic potential of C-peptide in kidney disease: a protocol for a systematic review and meta-analysis.C-peptide antioxidant adaptive pathways in β cells and diabetes.The clinical potential of low-level C-peptide secretion.Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.Enhanced insulin action following subcutaneous co-administration of insulin and C-peptide in rats.Molecular effects of C-Peptide in microvascular blood flow regulation.Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver diseaseEfficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice.ω-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunityFactors Associated with C-peptide Levels after Diagnosis in Children with Type 1 Diabetes Mellitus.Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients.Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.C-peptide levels and the risk of diabetes and pre-diabetes among Chinese women with gestational diabetes.C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells.Early transcriptional regulation by C-peptide in freshly isolated rat proximal tubular cells.Implicações clínicas da persistência de anti-GAD positivo e peptídeo C detectável em pacientes com diabetes melito tipo 1 de longa duraçãoAnemia is inversely associated with serum C-peptide concentrations in individuals with type 2 diabetes
P2860
Q24600478-950243A5-82DF-44C6-A3C5-8E47EA06AE86Q27012286-5EFD16D9-9CCF-4F77-B568-274F72C219CCQ33682573-3BDF8905-F393-4ADC-83F7-422201380636Q34585855-314871E3-4CCC-4DA0-BCFE-E728A50E76E0Q35437721-3EED923D-B1C8-41D8-93C1-9B1D1DA55504Q35857755-10388B71-4902-4A1F-8444-DFB17157FF12Q36365226-F3F1788A-6325-473A-90F0-C68C132DF803Q36493240-58BB10D0-DDA2-4BF1-93DE-81F60B6F33F3Q37070253-FACED3C4-2038-4198-AD87-FBDD1334388EQ37108880-AE12A5BD-3E1D-4D9E-83FD-7E707C72BBC3Q37147347-0DDE2CFF-14D5-4DD1-A67D-C30422E2AA2EQ37278130-413DC37E-936A-49E6-BEA0-EA3B5E3887C1Q37279083-ECDA6720-E11A-476C-BCA4-9F91AD74E748Q37598878-EEEA9B5F-720B-4FB6-A66B-E4D54B9C5F1DQ37640703-19AFD4E1-9AB3-476D-B10F-24F62540B86EQ37815562-162CFE07-622C-4498-A77C-9E309A65983CQ37940632-253E1B75-1CD4-4D68-8EC9-3EECAE71C845Q38086802-CBBCB103-77DD-4D49-BB7B-6640792CCC19Q38107138-AB97B977-F09D-41CF-B25B-30DD6F806657Q38112357-B1B72890-9626-4500-ABF2-211CD9960DB0Q38216760-9A5327BB-D90E-4F8A-81F6-1FC5432A2FA6Q38850708-0C238FCD-7363-4B6C-BC9A-707B8503E8EBQ38889362-56A63FF5-23E0-4B69-AC95-242D6CD5F63DQ38927961-616358AD-1233-47A7-B6B8-DC896802388DQ39096910-ABC916B5-E25F-49D7-84D6-22C3F26B0F40Q39224550-1AE8997B-FA53-43D5-BD20-520E1486E9DAQ39679120-13C3CE70-7DA9-4297-A556-AD05655E95FFQ41026519-D8D9A101-167F-4414-8AD6-E9EF782183D7Q41880842-84AC017D-258F-4047-B90C-C617C323F785Q42261993-96A2B503-8E23-4055-A889-2371305C5F08Q43713192-839C6360-3BCA-4A22-9679-52D7DADD59D4Q44916781-BC73B271-73E6-4378-8072-C8981326A458Q50053135-18AE590F-2418-4C61-8952-AEEF0E71DAC4Q53231716-7C0AFF5F-F175-4505-9FCB-76B86432A6B6Q54369086-1748922F-B8F9-4493-BC81-BBE1EE63FBB2Q57831167-64DDCDF2-5B02-4CED-9549-4E43A7B90380Q58789121-157DACBA-C494-4DEC-9D32-4F75C81FDAF7
P2860
Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Fasting plasma C-peptide and m ...... rt of type 1 diabetic patients
@en
Fasting plasma C-peptide and m ...... t of type 1 diabetic patients.
@nl
type
label
Fasting plasma C-peptide and m ...... rt of type 1 diabetic patients
@en
Fasting plasma C-peptide and m ...... t of type 1 diabetic patients.
@nl
prefLabel
Fasting plasma C-peptide and m ...... rt of type 1 diabetic patients
@en
Fasting plasma C-peptide and m ...... t of type 1 diabetic patients.
@nl
P2093
P2860
P356
P1433
P1476
Fasting plasma C-peptide and m ...... rt of type 1 diabetic patients
@en
P2093
Chiara Zucco
Francesco Panero
Giulia Novelli
Massimo Perotto
Olivia Segre
Paolo Cavallo-Perin
Paolo Fornengo
P2860
P304
P356
10.2337/DC08-1241
P407
P577
2008-11-18T00:00:00Z